ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO939

Inhibition of mPGES-1 Blocks High Glucose-Induced Mesothelial-to-Mesenchymal Transition of Peritoneal Mesothelial Cells

Session Information

Category: Dialysis

  • 703 Dialysis: Peritoneal Dialysis

Author

  • Luo, Qimei, Shunde Hospital of Southern Medical University, Foshan, China
Background

Peritoneal mesangial cells (PMC) undergoing mesothelial-to-mesenchymal transition (MMT) induced by chronic sterile inflammation promotes peritoneal fibrosis. Microsomal prostaglandin E2 synthase-1 (mPGES-1)-derived PGE2 plays an important role in inflammatory disease. Previous studies have shown that the secretion of PGE2 increased significantly in PMC under the circumstance of high glucose. This study aimed to investigate the role of mPGES-1 in phenotype transition of PMC.

Methods

The expression of mPGES-1 in human peritoneum tissue was evaluated by immunohistochemical. Human mesothelial cells were incubated with 138mmol/L glucose for various periods of time. After transfection of shRNA plasmid targeting mPGES-1, human mesothelial cells were incubated with 138mmol/L glucose and harvested for further analysis.

Results

Immunohistochemical analysis displayed mPGES-1 was expressed in the outermost layer of the peritoneal membrane and upregulated in peritoneal tissue of patients with peritoneal ultrafiltration failure. In cultured human mesothelial cells, high glucose time-dependently increased the expression of mPGES-1. Western blots confirmed that mPGES-1 was increased more than threefold by high glucose. Besides, application of mPGES-1 shRNA plasmid significantly reduced protein and mRNA expressions of mPGES-1 in human mesothelial cells. Moreover, inhibition of mPGES-1 in human mesothelial cells dramatically reversed levels of E-cadherin and decreased the synthesis of MMT-related proteins, such as fibronectin and vimentin.

Conclusion

The findings suggest that mPGES-1 could be activated by high glucose and could contribute to MMT of PMC.